A phase 1, single-dose study of fresolimumab, an anti-TGF-Β antibody, in treatment-resistant primary focal segmental glomerulosclerosis

Howard Trachtman, Fernando C. Fervenza, Debbie S. Gipson, Peter Heering, David R.W. Jayne, Harm Peters, Stefano Rota, Giuseppe Remuzzi, L. Christian Rump, Lorenz K. Sellin, Jeremy P.W. Heaton, James B. Streisand, Marjie L. Hard, Steven R. Ledbetter, Flavio Vincenti

Research output: Contribution to journal › Article › peer-review

176 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1, single-dose study of fresolimumab, an anti-TGF-Β antibody, in treatment-resistant primary focal segmental glomerulosclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences